Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.

800-TEMPLE-MED Schedule Appointment

Dr. Leah Croll Provides Perspective to ABC News about FDA’s Approval of New Nasal Spray to Treat Migraines

View All News

Leah Croll, MD, Assistant Professor of Clinical Neurology at the Lewis Katz School of Medicine at Temple University, provided perspective to ABC News about the U.S. Food and Drug Administration (FDA)’s approval of the drug Zavzpret. Zavzpret is the first and only migraine treatment of its kind to be offered in a nasal spray.